Appeals Board Upholds 4 FaceTec Biometric Liveness Detection Patents

Appeals Board Upholds 4 FaceTec Biometric Liveness Detection Patents

Biometric Update
Biometric UpdateJun 9, 2026

Companies Mentioned

Why It Matters

The ruling secures FaceTec’s core intellectual property, reinforcing its market leadership and opening a path to significant damages from competitors infringing its 3D liveness technology.

Key Takeaways

  • PTAB confirms validity of FaceTec’s four 3D liveness patents.
  • Jumio’s challenge fails, keeping FaceTec’s IP protected.
  • FaceTec can now seek injunctions and damages from Jumio and iProov.
  • Ruling reinforces FaceTec’s leadership in secure identity verification.
  • FaceTec’s portfolio totals 48 patents across biometric technologies.

Pulse Analysis

Biometric liveness detection has become a cornerstone of secure remote identity verification, especially as financial services and government agencies shift toward digital onboarding. The technology distinguishes real users from spoofing attacks using depth cues and motion analysis, a capability that differentiates providers in a crowded market. As regulatory bodies tighten anti‑fraud standards, firms that can demonstrate patented, proven liveness methods gain a competitive edge, attracting enterprise contracts that prioritize both security and compliance.

The PTAB’s affirmation of FaceTec’s four patents underscores the robustness of the inter partes review process in filtering weak claims while protecting genuine innovation. By upholding patents numbered 10,776,471; 11,157,606; 11,693,938; and 11,874,910, the board effectively shields FaceTec from having its core IP invalidated—a common tactic used to undermine rivals. This outcome not only strengthens FaceTec’s legal standing but also signals to the industry that high‑value biometric patents can survive rigorous scrutiny, encouraging continued investment in R&D and patent filing.

With its IP fortified, FaceTec is positioned to leverage litigation as a strategic tool against Jumio and iProov, potentially securing injunctions and sizable damages. The decision may also prompt other biometric vendors to reassess their own patent portfolios and licensing strategies, fostering a more litigious environment. For enterprises evaluating verification solutions, the ruling offers reassurance that FaceTec’s technology rests on defensible patents, reducing the risk of future disruption and supporting long‑term vendor stability.

Appeals board upholds 4 FaceTec biometric liveness detection patents

Comments

Want to join the conversation?

Loading comments...